Obese Patients With Untreated Dyslipidemias

Phase 3

Completed

• Conditions: Obesity; Dyslipidemia

• Registration Number: NCT00029835
• Lead Sponsor: Sanofi

Brief Summary

To assess the effect on weight loss and weight maintenance over a period of one year when prescribed with a hypocaloric diet in obese patients with untreated dyslipidemia

Detailed Description

Not available

Study Timeline

• Study Start: 2001-09
• Study First Submitted: 2002-01-23
• Study First Submitted QC: 2002-01-23
• Study First Posted: 2002-01-24
• Primary Completion: 2003-11
• Study Completion: 2003-11
• Status Verified: 2009-04
• Last Update Submitted: 2009-04-17
• Last Update Posted: 2009-04-20

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 1033

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Change from baseline in body weight at 1 year.

Secondary Outcome Measures

Name	Time	Method
Metabolic parameters

Trial Locations

Locations (26)

Clinic of Physicians and Surgeons, LTD; 🇺🇸 Mesa, Arizona, United States

Arizona Clinical Research Center, Inc.; 🇺🇸 Tucson, Arizona, United States

Irvine Center for Clinical Research (ICCR); 🇺🇸 Irvine, California, United States

Los Angeles Clinical Trials; 🇺🇸 Los Angeles, California, United States

Apexute; 🇺🇸 Santa Ana, California, United States

Clinical Research of South Florida; 🇺🇸 Coral Gables, Florida, United States

Radiant Research; 🇺🇸 Salt Lake City, Utah, United States

nTouch Research; 🇺🇸 South Bend, Indiana, United States

Bluegrass Clinical Research, Inc.; 🇺🇸 Louisville, Kentucky, United States

Johns Hopkins Women's Research Core; 🇺🇸 Lutherville, Maryland, United States

Scroll for more (16 remaining)